Literature DB >> 25392107

Hypertonic saline activates CD4+ and CD8+ T-lymphocytes in the small intestine to alleviate intestinal ischemia-reperfusion injury.

D-J Yang1, Z-X Zhu, H-B Fu, R-L Yan, J Chen, Y-J Cheng, Q-P Cai, Q Wang.   

Abstract

OBJECTIVE: Intestinal ischemia-reperfusion injury (I/R) is a common syndrome encountered in clinic following intestinal surgery, strangulated hernia, and shock. Hypertonic saline has been shown to prevent inflammatory tissue damages caused by I/R and regulate immunologic disorders in peripheral blood. However, the immunoregulatory effects of hypertonic saline on the small intestine response to intestinal I/R have not been reported.
MATERIALS AND METHODS: To investigate this, we created the intestinal I/R model by clamping the superior mesenteric artery in Sprague-Dawley rats. After 1 hour of ischemia, the vascular clamp was removed, and either normal saline (0.9% NaCl, NS group) or hypertonic saline (7.5% NaCl, HS group) was administered through the tail vein (6 ml/kg). The CD4(+) and CD(8+), primarily T-lymphocytes subpopulation yielded from the intestinal tissues, were determined by immunohistochemistry.
RESULTS: A pro-inflammatory cytokine, tumor necrosis factor (TNF)-α, and nuclear factor kappa B (NF-κB), a critical transcription factor for the TNF-α gene, were measured in the intestinal and lung tissues with ELISA. HS induced an increase in CD4(+) and CD8(+) T cells in the jejunum and ileum compared with the NS group. The levels of TNF-α and NF-κB in the intestinal and lung tissues were significantly decreased in the HS group compared with those of the NS group.
CONCLUSIONS: HS treatment may ameliorate the tissue damage induced by intestinal I/R. This protective effect is possibly due to its ability to activate the CD4(+) and CD8(+) T-lymphocytes cells in the intestinal tissues and inhibit the intestinal I/R-induced expression of pro-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25392107

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  CD4+ T Cell-Derived NGAL Modifies the Outcome of Ischemic Acute Kidney Injury.

Authors:  Sul A Lee; Sanjeev Noel; Johanna T Kurzhagen; Mohanraj Sadasivam; Phillip M Pierorazio; Lois J Arend; Abdel R Hamad; Hamid Rabb
Journal:  J Immunol       Date:  2019-12-30       Impact factor: 5.422

2.  Hypertonic Saline Dextran Ameliorates Organ Damage in Beagle Hemorrhagic Shock.

Authors:  Jing-xiang Zhao; Bo Wang; Guo-xing You; Ying Wang; Gan Chen; Quan Wang; Xi-gang Zhang; Lian Zhao; Hong Zhou; Yue-zhong He
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.